What question did this study set out to answer?

To evaluate the outcomes of second-line therapy in adult patients with B-cell acute lymphoblastic leukemia (ALL).

April 11, 2026Cancer0 citations

Outcome of second‐line therapy in adult B‐cell acute lymphoblastic leukemia

HKHagop KantarjianThe University of Texas MD Anderson Cancer Center WQWei QiaoThe University of Texas MD Anderson Cancer Center NJNitin JainThe University of Texas MD Anderson Cancer Center

Key Points

To evaluate the outcomes of second-line therapy in adult patients with B-cell acute lymphoblastic leukemia (ALL).
Analyzed outcomes of adult B-cell ALL patients receiving second-line therapy.
Utilized combination treatments of chemotherapy with blinatumomab or inotuzumab.
Focused on salvage therapy effectiveness.
Establishes a new expectation for outcomes in adult B-cell ALL during salvage treatment.
Combination therapies show improved effectiveness and should be standard care.

Abstract

This study establishes a modern expectation of outcome of adult B-cell ALL treated in salvage 1. Combination of chemotherapy and blinatumomab/inotuzumab should be a standard of care in adult B-cell ALL in salvage 1.

Ask AI

Helpful

Bookmark

View Full Paper